Mar 08, 2017 - Immune Design Corp.(IMDZ) reported fourth-quarter 2016 loss of 57 cents per share, in line with Zacks Consensus Estimate but narrower than the year-ago loss of 60 cents.
Mar 08, 2017 - Merck & Co., Inc. (MRK) and partner Pfizer, Inc. (PFE) announced that the FDA has accepted its new drug applications (NDA) for ertugliflozin as a monotherapy as well as two fixed-dose combination tablets.
Mar 06, 2017 - The Zacks Analyst Blog Highlights: Mylan, Roche, AstraZeneca, Merck and Sanofi
Mar 06, 2017 - Companies like Merck (MRK) are awaiting key FDA decisions this month.
Mar 03, 2017 - Immune Design Corp (IMDZ) is scheduled to report fourth-quarter 2016 results after the market closes on Mar 7.
Mar 03, 2017 - Quite a few companies including AstraZeneca (AZN) provided pipeline/regulatory updates this week.
Mar 03, 2017 - Aduro BioTech, Inc. (ADRO) reported fourth-quarter 2016 loss of 44 cents per share, wider than the Zacks Consensus Estimate of a loss of 38 cents.
Mar 01, 2017 - M&As, Pipeline Catalysts to Drive Pharma Sector
Feb 27, 2017 - Pharma Industry Outlook - February/March 2017
Aug 05, 2016 - As Bristol-Myers (BMY) tanks, check out these other large cap pharma stocks.